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Although balloon angioplasty has made considerable impact 
on the treatment of coronary, peripheral and renal obstruc- 
tive arterial disease, three major limitations of the techmque 
remain: recanalization, abrupt reclosure and restenosis. If 
more could be learned about these “three R’s” of angio- 
plasty and better techniques developed for addressing these 
limitations, perhaps the nonsurgical revascularization of 
atherosclerotic disease could be improved. 
It is now well known from experimental and postmortem 
pathologic studies (l-3) that balloon angioplasty acts by 
stretching and dissecting the arterial wall to produce a larger 
lumen. Unfortunately, this procedure does not eliminate any 
of the obstructive material, and the luminal surface is often 
quite disrupted such that a nidus for platelet and thrombus 
formation exists (4,5). These dilated vessels may “recoil.” 
or return to their original size, and smooth muscle cells may 
proliferate to cause restenosis. Therefore, the rationale 
behind most of the newer interventional devices is an 
attempt either to remove obstructive materials by cutting or 
ablating the lesion or to leave behind a smoother surface 
through sealing of dissections or placement of an endovas- 
cular stent, or to both remove obstruction and provide a 
smooth surface. 
The present study. Ultimately, randomized clinical trials 
will be required to determine whether these new devices can 
improve on the results currently available with conventional 
balloon angioplasty. Initially, however, there is a need for 
well conducted, objective analysis of consecutive series of 
patients to determine which particular lesion or disease state 
may be best suited for treatment with these devices (6). The 
article by von Polnitz et al. (7) in the current issue of the 
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Journal represents this type of well conducted series with a 
high percentage (87%) of angiographic follow-up necessary 
to evaluate the safety and efficacy of a device and to 
determine its potential clinical implications. If these newer, 
more expensive devices are to gain widespread clinical 
application and third party reimbursement, their advantages 
over conventional balloon angioplasty need to be deter- 
mined. 
Immediate results of peripheral atherectomy. In a series 
of 60 patients with a total of 94 lesions (63 stenoses and 31 
occlusions) von Polnitz et al. (7) report an acceptable 90% 
angiographic success rate and an 82% clinical success rate 
with peripheral atherectomy. The low complication rate 
included no perforations, acute closures or need for emer- 
gency bypass surgery. However, an analysis of various 
subsets of lesions reveals some important observations. For 
example, the authors note that their ability to adequately 
reduce iliac stenosis was “inferior” to results obtained with 
conventional balloon angioplasty despite the use of up to 
size 11F catheters. Furthermore, all occlusions had to be 
pretreated with another catheter to either “Dotter” or dilate 
a channel through the obstruction before the stiffer, larger 
profile atherectomy catheter could be passed. In superficial 
femoral artery stenoses, where the highest acute success 
was achieved, the mean lesion length was only 1.1 cm. 
Treatment of these types of lesions generally has a success 
rate of nearly 100% with current 5F balloon catheters. 
Because sheath access with 7F to 1 IF sheaths was a limiting 
factor in several cases in this series, one has to ask whether 
the acute success rate in superficial femoral artery stenoses 
could have been better with smaller, more flexible balloon 
catheters. 
Complications of large sheaths. In this series of peripheral 
atherectomy (7) the incidence of complications was gener- 
ally in the range of that observed with conventional balloon 
angioplasty; however, the 3.3% incidence rate of surgical 
evacuation of groin hematomas is high. In follow-up angiog- 
raphy, two new stenoses occurred in areas of sheath inser- 
tion. Therefore, concern must be raised about gaining access 
to the superficial femoral artery with use of an anterograde 
approach and large sheaths. Use of newer interventional 
devices such as atherectomy or laser catheters, which re- 
quire these larger sheaths, may lead to an increase in 
vascular complications (8) that would not be observed with 
SF balloon catheters. If a lesion can be successfully dilated 
with a smaller balloon catheter, this option may be safer than 
the use of devices that require larger sheaths and that 
increase the risk of vascular complications. The approach 
that the vascular radiologist and I use at Mount Sinai 
Medical Center is to attempt conventional balloon angio- 
plasty with a 5F catheter first and to resort to a larger sheath 
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BALLOON 
ANGIOPLASTY 
ATHERECTOMY Through subgroup analysis of 6 month angiographic results, 
a potential benefit of atherectomy was observed with eccen- 
tric lesions that had only a 12% restenosis rate. From a 
morphologic standpoint, directional atherectomy may be 
particularly well suited for eccentric lesions because balloon 
dilation may stretch only the normal portion of the vessel 
wall of these lesions (Fig. 1). These distended arteries may 
“recoil,” or return back to their original position, immedi- 
ately after dilation. Theoretically, directional atherectomy 
may be able to successfully remove these eccentric lesions 
and provide a better angiographic result. Clinically, our 
vascular radiologist and I have observed successful atherec- 
tomy in anecdotal cases in which balloon angioplasty could 
not adequately dilate an eccentric lesion. For long-term 
results, randomized trials are necessary to prove whether 
atherectomy is superior to balloon angioplasty of eccentric 
lesions. Unfortunately, the restenosis rate for occlusions 
was high in this series. 
Stretching of normal vessel “Directional” removal of 
wall by balloon dilation eccentric atheroma 
Recoil of normal wall 
producing “restenosis” 
Persistent potent lumen 
Figure 1. Morphologic mechanisms of balloon angioplasty and 
atherectomy. 
only if a laser device is required for recanalization or if 
atherectomy is required for an eccentric lesion that does not 
dilate. 
Use of angioscopy. von Polnitz et al. (7) describe the use 
of another innovative catheterization device, the angio- 
scope, and state that it permitted detection of residual 
obstructive material not seen with conventional angio- 
graphic techniques. Apparently, angioscopy was useful in 
deciding whether to remove additional material with further 
passes of the atherectomy catheter; however, the frequency 
with which this device led to further removal of tissue was 
not reported. Perhaps a future report will address this 
interesting concept and also discuss whether these decisions 
made by angioscopy have any effect on restenosis. 
Six month angiographic patency: results in eccentric le- 
sions. von Polnitz et al. (7) should be commended on their 
87%, 6 month angiographic follow-up. This rate of restudy is 
certainly higher than that in previous reports for peripheral 
balloon angioplasty or for any other interventional device. 
In summary, von Polnitz et al. (7) should be congratulated 
in the conduct of a study with an excellent 6 month angio- 
graphic follow-up. It will only be through careful investiga- 
tion, as in this study, that the true role of newer angioplasty- 
related devices will be determined. 
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